IMRX

IMMUNEERING CORP

IMRX·45254E107·US·Common Stock·Healthcare - Biotechnology-13D/G

CLASS A COM

IMRX (IMMUNEERING CORP) is held by 50 institutional investors as of Q1 2026. Largest holders: FMR LLC ($51.1M), MARSHALL WACE, LLP ($10.5M), PRICE T ROWE ASSOCIATES INC /MD/ ($9.6M). Net institutional sentiment: Mixed.

50
Holders
Avg rating(12 Elite)
$110.7M
Total Value
58% (57)
Fund Consensus
30 buying - 22 selling
IMRXSmart Money Verdict
View all
Held by 50 funds
12 elite
Who's Trading
InsiderZJZeskind Benjamin J.Buy $11KJun 23, 2026
InsiderHMHall Brett MatthewBuy $25KJun 15, 2026
ActivistBJBENJAMIN J. ZESKIND6.6%Jan 22, 2026
InsiderBEBrakewood Harold EugeneBuy $25KJan 16, 2026
InsiderSJSchall Thomas J.Buy $101KJan 15, 2026
ActivistEAEmpery Asset Management, LP5.0%Jan 15, 2026
InsiderHMHall Brett MatthewBuy $11KJan 15, 2026
InsiderNRNeufeld Leah RBuy $11KJan 13, 2026
InsiderFPFeinberg PeterBuy $87KJan 12, 2026
ActivistFMR LLCFMR LLC14.5%Oct 7, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.7M(+0.1%)$51.1M0.0%-23.42%
29
Increased
2M(+180.5%)$10.5M0.0%+4.39%
45
Decreased
1.8M(-8.3%)$9.6M0.0%-24.27%
0
Increased
1.5M(+3.8%)$7.9M0.0%-7.12%
29
Increased
1.1M(+2065.4%)$5.8M0.0%+2.52%
44
Increased
637,944(+3.2%)$3.4M0.0%-35.94%
27
Increased
447,278(+394.4%)$2.4M0.0%-3.84%
42
Increased
400,363(+201.8%)$2.1M0.0%-7.76%
42
Increased
376,284(+97.7%)$2M0.0%-11.90%
42
Increased
327,655(+2.8%)$1.7M0.0%-23.52%
26
Decreased
296,067(-39.5%)$1.6M0.0%+2.35%
0
Decreased
268,520(-88.8%)$1.4M0.0%-23.79%
0
Increased
244,771(+18.2%)$1.3M0.0%-15.75%
30
Increased
226,046(+145.0%)$1.2M0.0%-9.98%
41
New
156,424$824,3550.0%+3.23%
34
Decreased
150,847(-29.6%)$794,9630.0%-16.72%
0
Increased
131,286(+17.9%)$691,8770.0%+83.43%
29
Decreased
121,978(-47.1%)$642,8250.0%-24.42%
0
Increased
117,666(+7.9%)$620,1000.0%-35.20%
26
Decreased
105,507(-1.8%)$556,0220.0%-24.07%
0

Showing 1-20 of 57

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used